Global sales of allergy diagnostics stand at around USD 6220 million in 2024 and is slated to thrive at a CAGR of 7.7% through 2034. The adoption revenue of allergy diagnostics to attain a valuation of USD 13060.1 million by 2034.
The allergy diagnostic industry is set to experience consistent growth, propelled by various factors, like the prevalence of allergies, technological advancements, and the spurring awareness in patients. Allergies have cropped up as a considerable global health disorder, influencing millions of people globally and considerably straining the medical infrastructures.
A prominent catalyst of allergy diagnostic market growth is the accelerating occurrence of allergic conditions like food allergies, allergic rhinitis, asthma, and atopic dermatitis. Factors like environmental pollution, dietary transformations, and genetic inclination aid the surging frequency of allergies, requiring precise and well-timed diagnostics.
Technological innovations have modified allergy diagnostics, stimulating the production of efficient and accurate testing procedures. Advancements such as allergen microarrays, molecular diagnostics, and progressive immunoassays have considerably strengthened the preciseness, speed, and reactivity of allergy tests. This has allowed medical care providers to determine distinct allergens and personalize treatment tactics accordingly.
The spurring cognizance among patients and healthcare providers regarding the significance of timely detection and management of allergies catapults the allergen diagnostic market growth. Early identification not only enhances patient results but also assists minimized health expenditures linked with unrestrained allergic reactions.
North America and Europe prevail in the allergy diagnostics industry due to the pervasiveness of allergies, recognized healthcare infrastructure, and strong research and development activities. Asia Pacific allergy diagnostic sector is slated to experience steady growth because of the amplifying adoption of progressive diagnostic technologies, escalating healthcare expenses, and strengthening allergy awareness.
The ongoing advancements and innovation of diagnostic solutions, along with efforts to advance access to allergy examination, thrive the market growth and enhance clinical outcomes.
| Attributes | Description |
|---|---|
| Estimated Global Allergy Diagnostic Market Size (2024E) | USD 6220 million |
| Projected Global Allergy Diagnostic Market Value (2034F) | USD 13060.1 million |
| Value-based CAGR (2024 to 2034) | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growth Factors in the Allergy Diagnostics Sector
The dramatic change towards customized medicine concentrates on the demand for accurate and customized diagnostic approaches, ramping up the demand for allergy screening procedures. The allergy diagnostic providers should align their product portfolio with the shifting ecosystem of distinctive healthcare to satisfy the particular requirements of patients and medical service providers.
The focus on patient-centered care models highlights the significance of timely diagnosis, visionary management, and advances in patient results in allergic reactions. To fulfill the demands, providers prioritize the innovation of user-friendly, patient-centric testing solutions. This improves availability and compliance with allergy examinations, prospectively leading to better patient outcomes and widening market share.
The continued growth in healthcare expenditure, specifically in developing economies, assists the growth of the allergy diagnostic device market. The allergy diagnostic providers customize their market campaigns to cash on developing healthcare expenses and developing potential in the untrodden regions.
Restraints Adversely Influencing the Allergy Diagnostics Industry
The significant price of research and development along with extended innovation cycles inhibit the lucrativeness and competition in the allergy diagnostic industry. The vendors contend with booming innovation expenses, budgetary restrictions, and volatile regulatory schedules, constraining development and market penetration. This factor impedes the sales growth of allergy diagnostics between 2024 and 2034.
The dearth of qualified experts and expert proficiency in allergy diagnostics causes operational deterrents for allergy diagnostic providers, hindering service quality, advancements, and expansion initiatives. Hiring and preserving qualified professionals like precision medicine and cutting-edge allergy testing inhibits allergy diagnostic device market growth.
The global allergy diagnostic equipment market was valued at around USD 3450.5 million in 2019. The allergy diagnostic sales are projected to increase at a healthy CAGR of 10.2% attaining a market value of USD 5600 million by 2023.
Between 2019 and 2023, the allergic diagnostic industry saw considerable growth, catapulted by the occurrence of allergies, diagnostic technology innovations, and escalating consciousness about allergic issues. During this period, the allergy diagnostic device sector witnessed an intensification in demand for allergy testing equipment, immunoassay analyzers, and other diagnostic devices, with rising investments in research and development by vendors.
From 2024 to 2034, the revenue forecast for the market is slated to grow. Factors like the rising geriatric population, towering pollution issues, and broadening medical infrastructure in developing countries spur allergy diagnostic industry expansion. The evolution in precision medicine and tailored diagnostics transform allergy diagnostics, presenting customized solutions.
The strengthening focus on preventive medicine and timely identification of disease, along with favorable government schemes encouraging allergy diagnostics, augment allergy diagnostic market growth. The market sees steady demand and innovation, proffering profitable opportunities to cash on the shifting healthcare ecosystem and fulfill the diagnostic requirements of allergy patients globally.
Principal Consultant
The section below covers the forecast for the allergy diagnostic market in terms of countries. Information on key countries in several parts globally, including North America, Asia Pacific, Europe, and others, is mentioned.
The United States is the torchbearer of the allergy diagnostic industry in North America, with a CAGR of 7.1% between 2024 and 2034. In the Asia Pacific allergy diagnostic sector, China exhibits a CAGR of 7.2% through 2034, leaving behind Japan at 6.8%.
| Countries | CAGR 2024 to 2034 |
|---|---|
| China | 7.2% |
| United States | 7.1% |
| United Kingdom | 6.7% |
The allergy diagnostic sector in China observes swift growth because of catalysts like soaring healthcare expenses, amplifying allergy awareness, and innovations in diagnostic tools. The expanding population and urbanization shifts aid the proliferating allergy diagnostic sales.
Obstacles like constrained access to medical care in remote areas and regulatory intricacies inhibit the allergic diagnostics market growth. The partnership between regional and foreign vendors presents ample potential for the expansion of the allergic diagnostic industry.
The allergic diagnostics market in the United States is attributed to the rising incidence of allergies, stimulating demand for diagnostic testing. Technological innovation like the adoption of customized medicine approaches and molecular diagnostics, catapults the growth of the allergy diagnostic device industry.
The presence of deep-rooted healthcare infrastructure and favorable reimbursement rules assist the market expansion of allergy diagnostics. The pricing stress and health care improvements are an obstacle to providers, warranting advanced methods to stay competitive.
The allergy diagnostics industry in the United Kingdom encountered rapid growth because of spurring allergy incidence, amplifying healthcare expenses, and government schemes to enhance allergy management.
The adoption of POC testing and e-medicine solutions ramp up the availability of diagnostic services. The alliance between healthcare providers and diagnostic firms to produce consolidated allergy management solutions augments the growth of the allergy diagnostic industry.
The section contains information about the leading segments in the allergy diagnostic industry. In terms of product type category, the fungal allergy diagnostic segment accounts for a share of 68.8% by 2034. By allergen type category, the inhaled allergens segment is projected to prevail by garnering a share of 46.8% in 2034.
| Segment | Fungal Allergy Diagnostic |
|---|---|
| Value Share (2034) | 68.8% |
Rising cases of mold and yeast allergies in adults, and an evident surge in demand for fungal allergy diagnostics. This trend is escalated by the soaring cases of allergy-prompted asthma. To satisfy the fungal allergy diagnostics demand, providers are positioning themselves to present economical allergy testing solutions in rural areas. Identifying the perspective of the market, vendors are slated to cash on the elevating need for accessible allergy testing equipment.
| Segment | Inhaled Allergens |
|---|---|
| Value Share (2034) | 46.8% |
The inhaled allergens stimulate widespread allergic symptoms, comprising respiratory disorders such as asthma and rhinitis, which are predominant and consistently diagnosed disorders. This segment's ascendance in allergy diagnostics sales is characterized by the augmenting prevalence of respiratory allergies.
The ease of exposure to inhaled allergens intensifies the demand for diagnostic tools to recognize triggers rapidly. The provider cashs on this trend by strengthening innovative diagnostic solutions personalized to proficiently detect inhaled allergens, serving the widening market requirements.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Owing to the presence of reputed allergy diagnostic vendors the market is very competitive. To expand their global reach, allergy diagnostics device producers employ various promotional campaigns. The allergy diagnostics providers focus on using organic and inorganic strategies to solidify the global footprint.
Setting up a partnership with local suppliers to augment their supply chain and engaging in mergers and acquisitions are classic instances of inorganic approaches. Faster product innovations, patenting, and licensing procedures are emphasized.
Prominent allergy diagnostic equipment vendors stress providing attractive discounts and better prices to possess a greater market share in emerging economies.
Industry Updates
| Company | Astria Therapeutics, Inc. |
|---|---|
| Headquarter | United States |
| Recent Advancement |
Astria Therapeutics, Inc declared an agreement with Inchon’s Sciences in October 2023. This agreement envelops the OX40 portfolio, especially emphasizing on advancement of STAR-0310 for potential treatment of atopic dermatitis and other allergies and immune disorders. |
| Company | ALK, Inc. |
|---|---|
| Headquarter | Denmark |
| Recent Advancement |
ALK received FDA approval in January 2023 for widespread application of ODACTRA, a percutaneous immunotherapy tablet in the medication of house pollen-induced allergic rhinitis for people of age between 12 and 17. |
The market is bifurcated into fungal allergy diagnostic, and neutral lactase enzymes.
Key allergen type present in the industry include inhaled allergens, food allergens, drug allergens, and other allergens.
The report consists of key test types like in-vivo allergy tests and in-vitro allergy tests.
Key end users present in the industry include diagnostic laboratories, hospitals, academic research institutes, and other end users.
Analysis of the market has been carried out in key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa.
The sales analysis to attain USD 6220 million in 2024.
The industry to reach USD 13060.1 million by 2034.
The market infers a CAGR of 7.7% through 2034.
From 2019 to 2023, the market exhibited a HCAGR of 10.2%.
The fungal allergy diagnostic sector clutches a share of 68.8% in 2024.
The inhaled allergens sector to possess a share of 46.8% in 2024.
1. Executive Summary 2. Industry Introduction 2.1. Taxonomy 2.2. Market Definition 3. Market Trends and Success Factors 3.1. Macro-economic Factors 3.2. Market Dynamics 3.3. Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034 4.1. Historical Analysis 4.2. Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 7.1. Fungal Allergy Diagnostic 7.2. Neutral Lactase Enzymes 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Allergen Type 8.1. Inhaled Allergens 8.2. Food Allergens 8.3. Drug Allergens 8.4. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type 9.1. In-vivo Allergy Tests 9.2. In-vitro Allergy Tests 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 10.1. Diagnostic Laboratories 10.2. Hospitals 10.3. Academic Research Institutes 10.4. Others 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 11.1. North America 11.2. Latin America 11.3. Western Europe 11.4. South Asia 11.5. East Asia 11.6. Eastern Europe 11.7. Middle East & Africa 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Sales Forecast 2024 to 2034 by Product Type, Allergen Type, Test Type, and End User for 30 Countries 20. Competition Outlook 20.1. Market Structure Analysis 20.2. Company Share Analysis by Key Players 20.3. Competition Dashboard 21. Company Profile 21.1. Hitachi Chemical Co. Ltd 21.2. Thermo Fisher Scientific Inc. 21.3. Siemens Healthineers 21.4. Danaher Corporation 21.5. HOB Biotech Group Co 21.6. bioMérieux 21.7. Hycor Biomedical Inc. 21.8. Stallergenes Greer 21.9. R-Biopharm AG 21.10. Lincoln Diagnostics Inc.
Explore Healthcare Insights
View Reports
Allergy Diagnostic Market
